Thanks TZ- it was a good day to do it- we sort of stole the cheapies away from Block and Monk yesterday! lol

I don't think we're fighting it at all- think this is our best indicator of where we're going!

EIGH chart notes. EIGH gang- does this look correct to you? Thanks
TNZ

Obviously this is pretty basic chart analysis- but how can you argue with a trendline?

Good adds!

Cheezus... :)

Yes sir I do.. Tried to hit em with my pea shooter earlier

We will see- she gets home in about an hour! Time to plan some distractions..

There are more there than I can soak up; just threw the rent money at it lol :P

Excuse me?

throwing 10k shares at the ask. i know the boss(es) are off site today. think this is what they'd be doing here. (minus several zeroes)

Does someone with level 2 see what that was? Market sell? Something else?

That's a bit of a whack..

CSLI really appeared to move when they opened the B/A spread up- will be interesting to see how high this one goes over the coming weeks IMO

and a CSLI bid UT

Not for long with CDIV, I'll bet you a box of donuts.

It's a quiet day in the market in general from what I can tell. .065's on sale- today only! :)

Did we pick up a new boardmark? IMO these days provide perspective- we can't have up days all the time, and CDIV is holding well compared to a lot of other stocks. I have this one on 'set and forget' until we hit a quarter!

OPXA Weekly Chart and Tovaxin Timeline

I value CSLI at .02, holding strong.

OPXA 2.50 has traded in a range of 2.11 - 2.86; exciting day for this forward event play.

OPXA cycles the float quickly when it moves; this action is pre-news, and there are always clear buy opportunities prior to news breaking.

OPXA is on my watchlist for 3 forward event plays this year, specifically as follows;

1. I expect news regarding a progress payment from Novartis under OPXA's deal with Novartis for islet stem cell technology (diabetes potential). When it occurs, I expect will provide a temporary +33% impact to OPXA's PPS. The deal with Novartis has been valued by OPXA in prior PR and SEC filings at $50mm.

2. I expect OPXA to announce progress on FDA filing of its Tovaxin Phase IIb in the first half of this year. When it occurs, I expect this forward event play to provide a temporary +300% impact to OPXA's PPS, and then re-base OPXA higher by 75%.

3. I expect OPXA to announce progress on a partnership to commercialize Tovaxin in 2010. When it occurs, I expect this to provide significant temporary impact to OPXA's PPS of +100% or higher (depending on how much rebase is observed from Tovaxin's FDA progress).

OPXA is a Naz big board play. Tovaxin is a promising therapy for Multiple Sclerosis- a $9b global market.

OPXA's recent chart and insider buying signal to me that this will be an exciting quarter.

Tovaxin's first FDA trial yielded statistically significant efficacy and safety data.

OPXA entered 2010 with a strong cash position to fund operations and recently completed a direct placement secondary offering to raise cash for Tovaxin's continued development. I anticipate no further dilution until substantial news breaks.

Best wishes to all in 2010
tnzalu

Morning CDIV winners!

Wish I knew. Been hunting all day. I'm guessing news leak like everyone else, but we'll just have to wait until tomorrow.

:) indeed, sir

YEEEEEHAAAAAWWW!!!!

Can I yell now boss?

Berger, Apple and Associates has since merged with another CPA firm to become Singer, Berger, and Press.

Alan W. Berger is the principal CPA at Singer, Berger and Press.

Singer, Berger and Press advised me that there is no association between their firm and the offices of Stephen B. Berger, Esq, CSLI's stated counsel.

Oh man.. I'm not sure I wanna know.. :)

I count it my good fortune that the case for CDIV as an investment made sense to me where others didn't.

little love tap at the ask, not filling. MMs holding this down?

I can't imagine how painful that would be.. makes me hurt just thinking about it..

Royal, I expect you to yell in native MM.. 101101 :)

I can't help it! CDIV has me all shades of green..

That's a good point Monk- I hadn't thought about it before, but if you sold air shares at .08, a last ditch cover at .065 would seem a very rational thing to do.

You won't hear me complaining! Just yelling :)

They can't all be up days, I've got no beef with a 6% step back. Other stocks I hold are doing the same. It's a breather, as Monk says- "makes a nice stair step".

Excellent annotated chartwork, MW.

Morning Mr. Monk Sir!